1. Home
  2. CARM vs ULY Comparison

CARM vs ULY Comparison

Compare CARM & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • ULY
  • Stock Information
  • Founded
  • CARM 2016
  • ULY 2013
  • Country
  • CARM United States
  • ULY United States
  • Employees
  • CARM N/A
  • ULY N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • CARM Health Care
  • ULY
  • Exchange
  • CARM Nasdaq
  • ULY Nasdaq
  • Market Cap
  • CARM 8.4M
  • ULY 7.4M
  • IPO Year
  • CARM N/A
  • ULY N/A
  • Fundamental
  • Price
  • CARM $0.42
  • ULY $5.72
  • Analyst Decision
  • CARM Hold
  • ULY Strong Buy
  • Analyst Count
  • CARM 5
  • ULY 1
  • Target Price
  • CARM $0.90
  • ULY $12.00
  • AVG Volume (30 Days)
  • CARM 42.1M
  • ULY 1.3M
  • Earning Date
  • CARM 08-07-2025
  • ULY 08-11-2025
  • Dividend Yield
  • CARM N/A
  • ULY N/A
  • EPS Growth
  • CARM N/A
  • ULY N/A
  • EPS
  • CARM N/A
  • ULY N/A
  • Revenue
  • CARM $19,964,000.00
  • ULY $134,085,000.00
  • Revenue This Year
  • CARM N/A
  • ULY N/A
  • Revenue Next Year
  • CARM N/A
  • ULY $23.08
  • P/E Ratio
  • CARM N/A
  • ULY N/A
  • Revenue Growth
  • CARM 32.45
  • ULY N/A
  • 52 Week Low
  • CARM $0.14
  • ULY $2.99
  • 52 Week High
  • CARM $1.90
  • ULY $22.50
  • Technical
  • Relative Strength Index (RSI)
  • CARM 52.02
  • ULY 53.94
  • Support Level
  • CARM $0.41
  • ULY $4.00
  • Resistance Level
  • CARM $0.56
  • ULY $9.42
  • Average True Range (ATR)
  • CARM 0.13
  • ULY 0.80
  • MACD
  • CARM -0.01
  • ULY 0.34
  • Stochastic Oscillator
  • CARM 20.33
  • ULY 41.70

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: